EI2BB Polyclonal Antibody

Rabbit Anti-EI2BB Polyclonal Antibody

Product Specifications

Background

EIF2B2 (Eukaryotic Translation Initiation Factor 2B Subunit Beta) is a Protein Coding gene. Diseases associated with EIF2B2 include Leukoencephalopathy With Vanishing White Matter and Childhood Ataxia With Central Nervous System Hypomyelination/Vanishing White Matter. Among its related pathways are Regulation of lipid metabolism Insulin signaling-generic cascades and Beta-Adrenergic Signaling. EIF2B2 encodes the beta subunit of eukaryotic initiation factor-2B (EIF2B) . EIF2B is involved in protein synthesis and exchanges GDP and GTP for its activation and deactivation.

CAS Number

9007-83-4

Product Name Alternative

Translation initiation factor eIF-2B subunit beta; S20I15; S20III15; eIF-2B GDP-GTP exchange factor subunit beta

Gene ID

8892

Accession Number

P49770

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from part region of human EI2BB protein at amino acid sequence of 50-130

Clonality

Polyclonal

Tag

EI2BB

Applications

WB, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

38kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

The antibody detects endogenous levels of EI2BB protein

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; ELISA 1:5000-20000